HCM
DGX icon

Howard Capital Management’s Quest Diagnostics DGX Stock Holding History

Howard Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Buy
+1,421
New +$279K ﹤0.01% 374
2026
Q1 		– Sell
-1,261
Closed -$219K – 357
2025
Q4 		$219K Buy
1,261
+4
+0.3% +$728 ﹤0.01% 413
2025
Q3 		$240K Buy
+1,257
New +$223K ﹤0.01% 393

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Howard Capital Management's DGX Position: Q2 2026 in Review

Howard Capital Management opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,421 shares worth $301K. The stake represents ﹤0.01% of the portfolio and ranks #374 among its holdings. This is a return to the name: Howard Capital Management previously reported a position in DGX as recently as Q4 2025.

Howard Capital Management first reported a position in DGX in Q3 2025 and has held it in 3 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Howard Capital Management held 1,421 shares of Quest Diagnostics worth $301K as of Q2 2026.
  • Quest Diagnostics was a new Howard Capital Management position in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Howard Capital Management's portfolio in Q2 2026, its #374 holding.
  • Howard Capital Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.